Knowing the difference between preclinical and nonclinical studies can make a big impact. It helps drug developers plan smarter programs, explain their work more clearly to the FDA, and use time and money more wisely. This guide explains everything you need to know about preclinical vs nonclinical studies in pharmaceutical development. What Does Preclinical Mean?

Pharmaceutical companies lose millions each year when technology transfers fail.  A recent study found that up to 50% of tech transfer projects experience large delays or quality issues during scale-up. Tech transfer pharma processes move products from development labs to commercial manufacturing facilities. When done right, these transfers maintain product quality while meeting regulatory requirements

A recent study by BioPharma Services found that good planning and execution of IND-enabling studies are vital for moving through the drug development process well and increasing the chances of IND approval. The main challenge facing drug companies is the complex coordination needed between pharmacology, toxicology, and regulatory science teams. Your ind enabling studies serve